ABVC BioPharma (ABVC) SEC Filings & 10K Form $0.54 +0.00 (+0.22%) As of 03:46 PM Eastern Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Recent ABVC BioPharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView11/15/20242:26 PMABVC BioPharma (Filer)Form 424B411/15/20242:28 PMABVC BioPharma (Filer)Form 424B411/15/20242:30 PMABVC BioPharma (Filer)Form 424B411/15/20242:31 PMABVC BioPharma (Filer)Form 424B411/14/20246:33 PMABVC BioPharma (Subject)Lind Global Fund II LP (Filed by)Form SC 13G/A11/14/20248:25 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/14/20247:30 AMABVC BioPharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 11/04/20244:00 PMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/25/202411:21 AMABVC BioPharma (Filer)Form 424B410/18/20244:23 PMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/10/20243:01 PMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) Get the Latest News and Ratings for ABVC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ABVC BioPharma and its competitors with MarketBeat's FREE daily newsletter. 08/20/20243:30 PMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/16/20243:30 PMABVC BioPharma (Filer)Form 424B408/16/20243:30 PMABVC BioPharma (Filer)Form 424B408/16/20243:31 PMABVC BioPharma (Filer)Form 424B408/15/20246:00 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/14/20242:18 PMABVC BioPharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/07/20244:15 PMABVC BioPharma (Filer)Form 424B508/01/202411:15 PMABVC BioPharma (Filer)Form EFFECT07/26/20243:30 PMABVC BioPharma (Filer)Form POS AM07/23/20244:00 PMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/01/202411:15 PMABVC BioPharma (Filer)Form EFFECT06/25/20244:15 PMABVC BioPharma (Filer)Form 8-K/A06/24/20244:15 PMABVC BioPharma (Filer)Form 8-K/A06/21/20244:02 PMABVC BioPharma (Filer)Form S-1Registration statement under Securities Act of 1933 05/24/20247:00 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/23/20244:00 PMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/22/20241:31 PMABVC BioPharma (Filer)Form 424B405/15/20244:00 PMABVC BioPharma (Filer)Form NT 10-Q05/15/20248:00 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/09/20248:27 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/30/202411:15 PMABVC BioPharma (Filer)Form EFFECT04/25/20241:38 PMABVC BioPharma (Filer)Form POS AM04/19/20244:26 PMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/17/20247:30 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/05/20241:47 PMABVC BioPharma (Filer)Form 424B404/01/202411:15 PMABVC BioPharma (Filer)Form EFFECT03/26/20247:35 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/25/20243:30 PMABVC BioPharma (Filer)Form DEFA14A03/22/20244:01 PMABVC BioPharma (Filer)Form S-1/A03/14/202411:08 AMABVC BioPharma (Filer)Form DEFA14A$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now.03/14/202410:33 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/14/20248:04 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/13/20244:14 PMABVC BioPharma (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 02/29/20243:32 PMABVC BioPharma (Filer)Form 8-K/A02/13/20246:59 PMABVC BioPharma (Subject)Lind Global Fund II LP (Filed by)Form SC 13G/A02/09/20244:04 PMABVC BioPharma (Filer)Form S-1/A02/08/20248:30 AMABVC BioPharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies CTXR 10Q Form LSB 10Q Form LGVN 10Q Form NAII 10Q Form DRRX 10Q Form CDIO 10Q Form ATHE 10Q Form LVTX 10Q Form GDTC 10Q Form EQ 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:ABVC) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABVC BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ABVC BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.